We previously showed that individuals producing higher levels of precursor B cells (CD19+CD10+) develop less severe forms of COVID-19 (36), which may be explained by their increased ability to clear the virus due to a pro-apoptotic B cell profile and accelerated cell turnover. This evidence concerns the gene CD19 and COVID-19.